Side effects of radiotherapy and chemoradiotherapy
Radiotherapy and chemoradiation (or chemoradiotherapy) for pancreatic cancer affects people in different ways. Here people talk about what it was like for them. Some people...
Stereotactic ablative radiotherapy (SABR) or radiosurgery is a form of highly focused radiotherapy. It delivers a high dose of radiation in a single or small number of treatments. SABR isn’t widely available in hospitals in the UK.
Here, people talk about their experiences of having CyberKnife™ which is the brand name of a type machine that gives SABR.
CyberKnife treatment requires no anaesthestic and patients can usually be treated and go home on the same day.
Two men told us about their CyberKnife™ treatment at a private clinic. Michael had a Whipple’s operation followed by chemoradiotherapy but the cancer came back later. He was delighted when doctors decided he was suitable for CyberKnife™ treatment.
Peter’s pancreatic cancer was not suitable for surgery. He had some chemotherapy and then heard about SABR. He asked his consultant to refer him to a doctor in a private clinic that provided this treatment.
Before SABR takes place, you will have a scan to take pictures of the tumour. This is so that doctors can plan the treatment.
During treatment you will inside a plastic mould that is specially made to the shape of your body. This is to help you keep still for the treatment.
The side effects of SABR are similar to radiotherapy. There are fewer treatments with SABR but the risk of bleeding and bowel ulceration is higher than for standard radiotherapy and chemoradiotherapy. Michael had some quite bad side effects but Peter had none.
Radiotherapy and chemoradiation (or chemoradiotherapy) for pancreatic cancer affects people in different ways. Here people talk about what it was like for them. Some people...
Irreversible Electroporation (IRE) is a non-thermal cell-destruction technique used when pancreatic cancer cannot be removed by surgery. Non-thermal high energy pulses of electricity aim to...